April 20, 2016
Research shines new light on malignant hyperthermia
The rare but very serious condition of malignant hyperthermia (MH) remains a risk at all surgical facilities, including ambulatory surgical centers (ASCs). MH occurs in about one in 50,000 adults under anesthesia, and one in about 12,000 children, which translates to one or two deaths annually in the United States. When it does strike, MH often is fatal if not treated within minutes. And the only antidote is a very expensive drug.
Free Daily News
- Study: Adenotonsillectomy reduces healthcare use in children with mild sleep-disordered breathing
- Introducing New Leader Toolkit: Your guide to OR leadership success
- Northwestern tests autonomous blood draw robot
- Unplanned hospital admissions post ASC visits remain exceptionally low, study finds
- Cardiology efficiency, orthopedic revenue surge as ASCs navigate growing complexity
- Study: BMI, hidden tumors complicate intubation
- New 7T MRI technique pinpoints hidden epilepsy-causing brain lesions
- Wildfires linked to longer postop hospital stay following lung cancer surgery, study finds
- Smart t-shirt enables earlier discharge, safer recovery after urological cancer surgery
- Study compares robotic, laparoscopic cholecystectomy cost drivers
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement